|
|
||||
 | ||||
|
|
Select from the search options to widen or narrow the search results.
Suppression of Ovarian Function Trial (SOFT) The purpose of this trial is to look at suppressing the functions of the ovaries plus giving tamoxifen or exemestane is better at preventing the return of breast cancer than just giving tamoxifen alone in premenopausal women. To participate in this study you must be:
For more information atElkhorn, please Contact Carol ThomasBS MT CCRC at 414-649-5605 carol.thomas@aurora.org Principal Investigator: Rossana Madamba, MD, For more information at Aurora Bay-care in Greenbay contact Lori McElrone CCRC 920-288-4174 or lori.mcelrone@aurora.org Principal Investigator: Dhiman Patel, M.D., For more information at Milwaukee/ Slinger Please contact Pamela Rynes RN BSN CCRC at 414-649-6067 or pam.rynes@aurora.org Principal Investigator, Johnathan Treisman, MD For Information at Oshkosh, Please contact Barb Esselman at 920-456-7880, or barbara.esselman@aurora.org Principal Investigator, Zahid Dar, MD Clinical trial location(s)AMG - ABMC (incl. VLCC)2845 Greenbrier Road Green Bay, WI 54308-8900 Aurora St. Luke's Medical Center VLCC - Elkhorn VLCC - Slinger VLCC- Oshkosh
[ previous page ]
|
||
 |
||||
 |
 |
 |
|
 |
